What is Monopar Therapeutics's return on invested capital?

Monopar Therapeutics (MNPR) reported return on invested capital of -38.6% in Q1 2026.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Monopar Therapeutics MNPR Return on invested capital

Return on invested capital at other companies

Bristol-Myers SquibbBMY

13%+4.2pp

Eli LillyLLY

42%+16.6pp

Bausch Health CompaniesBHC

3.2%-0.7pp

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

Prime MedicinePRME

-175.4%+69.2pp

Amylyx Pharmaceuticals, Inc.AMLX

-165.3%+14.1pp

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M-62.2%

Net income-$3.9M-48.3%

EPS (diluted)-$0.19—

Balance sheet

See full

Cash & equivalents$52.5M+32.3%

Total debt$230.4K+2,692%

Total equity$135.4M+153%

Total assets$138.0M+150%

Cash flow

See full

Operating cash flow-$3.5M+38.7%

Valuation

See full

Market cap$587.04M+192%

Enterprise value$534.72M+232%

Returns & leverage

See full

Return on equity-15.9%-6.6pp

Debt / equity0×0.0×

Current ratio56×—

Where this comes from

Calculated from Monopar Therapeutics’s reported figures.

nopat/invested capital=-38.6%

Based on trailing twelve months.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monopar Therapeutics's return on invested capital?: Monopar Therapeutics (MNPR) reported return on invested capital of -38.6% in Q1 2026.
What does return on invested capital mean?: Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.